Robert S Kerrison1, Andrew Prentice2, Sarah Marshall2, Sameer Choglay2,3, Michael Levitan4, Marsha Alter4, Alex Ghanouni5, Lesley McGregor5,6, Christian von Wagner7. 1. Research Department of Behavioural Science and Health, University College London, London, WC1E 7HB, UK. Robert.kerrison.13@ucl.ac.uk. 2. St Mark's Bowel Cancer Screening Centre, St Mark's Hospital, Watford Road, Harrow, UK. 3. Public Health England, Skipton House, London, UK. 4. The Middlesex Pharmaceutical Group of Local Pharmaceutical Committees, London, UK. 5. Research Department of Behavioural Science and Health, University College London, London, WC1E 7HB, UK. 6. Division of Psychology, University of Stirling, Stirling, UK. 7. Research Department of Behavioural Science and Health, University College London, London, WC1E 7HB, UK. C.Wagner@ucl.ac.uk.
Abstract
BACKGROUND: To date, research exploring the public's awareness of bowel cancer has taken place with predominantly white populations. To enhance our understanding of how bowel cancer awareness varies between ethnic groups, and inform the development of targeted interventions, we conducted a questionnaire study across three ethnically diverse regions in Greater London, England. METHODS: Data were collected using an adapted version of the bowel cancer awareness measure. Eligible adults were individuals, aged 60+ years, who were eligible for screening. Participants were recruited and surveyed, verbally, by staff working at 40 community pharmacies in Northwest London, the Harrow Somali association, and St. Mark's Bowel Cancer Screening Centre. Associations between risk factor, symptom and screening awareness scores and ethnicity were assessed using multivariate regression. RESULTS: 1013 adults, aged 60+ years, completed the questionnaire; half were of a Black, Asian or Minority ethnic group background (n = 507; 50.0%). Participants recognised a mean average of 4.27 of 9 symptoms and 3.99 of 10 risk factors. Symptom awareness was significantly lower among all ethnic minority groups (all p's < 0.05), while risk factor awareness was lower for Afro-Caribbean and Somali adults, specifically (both p's < 0.05). One in three adults (n = 722; 29.7%) did not know there is a Bowel Cancer Screening Programme. Bowel screening awareness was particularly low among Afro-Caribbean and Somali adults (both p's < 0.05). CONCLUSION: Awareness of bowel cancer symptoms, risk factors and screening varies by ethnicity. Interventions should be targeted towards specific groups for whom awareness of screening and risk factors is low.
BACKGROUND: To date, research exploring the public's awareness of bowel cancer has taken place with predominantly white populations. To enhance our understanding of how bowel cancer awareness varies between ethnic groups, and inform the development of targeted interventions, we conducted a questionnaire study across three ethnically diverse regions in Greater London, England. METHODS: Data were collected using an adapted version of the bowel cancer awareness measure. Eligible adults were individuals, aged 60+ years, who were eligible for screening. Participants were recruited and surveyed, verbally, by staff working at 40 community pharmacies in Northwest London, the Harrow Somali association, and St. Mark's Bowel Cancer Screening Centre. Associations between risk factor, symptom and screening awareness scores and ethnicity were assessed using multivariate regression. RESULTS: 1013 adults, aged 60+ years, completed the questionnaire; half were of a Black, Asian or Minority ethnic group background (n = 507; 50.0%). Participants recognised a mean average of 4.27 of 9 symptoms and 3.99 of 10 risk factors. Symptom awareness was significantly lower among all ethnic minority groups (all p's < 0.05), while risk factor awareness was lower for Afro-Caribbean and Somali adults, specifically (both p's < 0.05). One in three adults (n = 722; 29.7%) did not know there is a Bowel Cancer Screening Programme. Bowel screening awareness was particularly low among Afro-Caribbean and Somali adults (both p's < 0.05). CONCLUSION: Awareness of bowel cancer symptoms, risk factors and screening varies by ethnicity. Interventions should be targeted towards specific groups for whom awareness of screening and risk factors is low.
Authors: Eline H Schreuders; Arlinda Ruco; Linda Rabeneck; Robert E Schoen; Joseph J Y Sung; Graeme P Young; Ernst J Kuipers Journal: Gut Date: 2015-06-03 Impact factor: 23.059
Authors: Rebecca J Beeken; Alice E Simon; Christian von Wagner; Katriina L Whitaker; Jane Wardle Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-08-29 Impact factor: 4.254
Authors: Kathryn Robb; Jane Wardle; Sarah Stubbings; Amanda Ramirez; Joan Austoker; Una Macleod; Sara Hiom; Jo Waller Journal: J Med Screen Date: 2010 Impact factor: 2.136
Authors: Charlotte Vrinten; Sandro Stoffel; Rachael H Dodd; Jo Waller; Yoryos Lyratzopoulos; Christian von Wagner Journal: J Med Screen Date: 2019-05-01 Impact factor: 2.136
Authors: Mohamedraed Elshami; Mohammad F Dwikat; Ibrahim Al-Slaibi; Mohammed Alser; Balqees M Mohamad; Wejdan S Isleem; Adela Shurrab; Bashar Yaghi; Yahya Ayyash Qabaja; Shoruq A Naji; Fatima K Hmdan; Mohammed M Ayyad; Raneen R Sweity; Remah T Jneed; Khayria A Assaf; Maram E Albandak; Mohammed M Hmaid; Iyas I Awwad; Belal K Alhabil; Marah N Alarda; Amani S Alsattari; Moumen S Aboyousef; Omar A Aljbour; Rinad AlSharif; Christy T Giacaman; Ali Y Alnaga; Ranin M Abu Nemer; Nada M Almadhoun; Sondos M Skaik; Bettina Bottcher; Nasser Abu-El-Noor Journal: JCO Glob Oncol Date: 2022-06